Key points are not available for this paper at this time.
The Synuclein-One study is an NIH-funded 30-site multicenter trial that included 50 patients with dementia with Lewy bodies (DLB) and 27 with mild cognitive impairment. Here we report the detection of cutaneous phosphorylated alpha-synuclein (P-SYN) in patients with DLB and MCI.
Gibbons et al. (Tue,) studied this question.